<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 19:05:24 -0700</creation_date>
  <update_date>2013-01-15 19:05:24 -0700</update_date>
  <accession>HMDBP02456</accession>
  <secondary_accessions>
    <accession>7950</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>B cell differentiation factor I</synonym>
    <synonym>Eosinophil differentiation factor</synonym>
    <synonym>IL-5</synonym>
    <synonym>T-cell replacing factor</synonym>
    <synonym>TRF</synonym>
  </synonyms>
  <gene_name>IL5</gene_name>
  <general_function/>
  <specific_function>Factor that induces terminal differentiation of late- developing B-cells to immunoglobulin secreting cells</specific_function>
  <pathways>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB15481</accession>
      <name>Pranlukast</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>growth factor activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>signal transducer activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>receptor binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>cytokine activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hematopoietin/interferon-class (d200-domain) cytokine receptor binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>interleukin-5 receptor binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>response to stimulus</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>response to biotic stimulus</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>defense response</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>immune response</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>extracellular region</description>
      <go_id/>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Secreted</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>Chromosome:5</chromosome_location>
    <locus>5q31.1</locus>
    <gene_sequence>&gt;405 bp
ATGAGGATGCTTCTGCATTTGAGTTTGCTAGCTCTTGGAGCTGCCTACGTGTATGCCATC
CCCACAGAAATTCCCACAAGTGCATTGGTGAAAGAGACCTTGGCACTGCTTTCTACTCAT
CGAACTCTGCTGATAGCCAATGAGACTCTGAGGATTCCTGTTCCTGTACATAAAAATCAC
CAACTGTGCACTGAAGAAATCTTTCAGGGAATAGGCACACTGGAGAGTCAAACTGTGCAA
GGGGGTACTGTGGAAAGACTATTCAAAAACTTGTCCTTAATAAAGAAATACATTGACGGC
CAAAAAAAAAAGTGTGGAGAAGAAAGACGGAGAGTAAACCAATTCCTAGACTACCTGCAA
GAGTTTCTTGGTGTAATGAACACCGAGTGGATAATAGAAAGTTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>134</residue_number>
    <molecular_weight>15238.0</molecular_weight>
    <theoretical_pi>8.23</theoretical_pi>
    <pfams>
      <pfam>
        <name>IL5</name>
        <pfam_id>PF02025</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
      <region>1-19</region>
    </signal_regions>
    <protein_sequence>&gt;Interleukin-5 precursor
MRMLLHLSLLALGAAYVYAIPTEIPTSALVKETLALLSTHRTLLIANETLRIPVPVHKNH
QLCTEEIFQGIGTLESQTVQGGTVERLFKNLSLIKKYIDGQKKKCGEERRRVNQFLDYLQ
EFLGVMNTEWIIES</protein_sequence>
  </protein_properties>
  <genbank_protein_id>33836</genbank_protein_id>
  <uniprot_id>P05113</uniprot_id>
  <uniprot_name>IL5_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1HUL</pdb_id>
  </pdb_ids>
  <genbank_gene_id>X04688</genbank_gene_id>
  <genecard_id>IL5</genecard_id>
  <geneatlas_id>IL5</geneatlas_id>
  <hgnc_id>HGNC:6016</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Azuma C, Tanabe T, Konishi M, Kinashi T, Noma T, Matsuda F, Yaoita Y, Takatsu K, Hammarstrom L, Smith CI, et al.: Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res. 1986 Nov 25;14(22):9149-58.</reference_text>
      <pubmed_id>3024129</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tanabe T, Konishi M, Mizuta T, Noma T, Honjo T: Molecular cloning and structure of the human interleukin-5 gene.  J Biol Chem. 1987 Dec 5;262(34):16580-4.</reference_text>
      <pubmed_id>2824500</pubmed_id>
    </reference>
    <reference>
      <reference_text>Campbell HD, Tucker WQ, Hort Y, Martinson ME, Mayo G, Clutterbuck EJ, Sanderson CJ, Young IG: Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc Natl Acad Sci U S A. 1987 Oct;84(19):6629-33.</reference_text>
      <pubmed_id>3498940</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yokota T, Coffman RL, Hagiwara H, Rennick DM, Takebe Y, Yokota K, Gemmell L, Shrader B, Yang G, Meyerson P, et al.: Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7388-92.</reference_text>
      <pubmed_id>2823259</pubmed_id>
    </reference>
    <reference>
      <reference_text>Minamitake Y, Kodama S, Katayama T, Adachi H, Tanaka S, Tsujimoto M: Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cells. J Biochem (Tokyo). 1990 Feb;107(2):292-7.</reference_text>
      <pubmed_id>2361960</pubmed_id>
    </reference>
    <reference>
      <reference_text>Proudfoot AE, Davies JG, Turcatti G, Wingfield PT: Human interleukin-5 expressed in Escherichia coli: assignment of the disulfide bridges of the purified unglycosylated protein. FEBS Lett. 1991 May 20;283(1):61-4.</reference_text>
      <pubmed_id>2037074</pubmed_id>
    </reference>
    <reference>
      <reference_text>Milburn MV, Hassell AM, Lambert MH, Jordan SR, Proudfoot AE, Graber P, Wells TN: A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature. 1993 May 13;363(6425):172-6.</reference_text>
      <pubmed_id>8483502</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Hojo M, Suzuki M, Maghni K, Hamid Q, Powell WS, Martin JG: Role of cysteinyl leukotrienes in CD4(+) T cell-driven late allergic airway responses. J Pharmacol Exp Ther. 2000 May;293(2):410-6.</reference_text>
        <pubmed_id>10773010</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Nabe T, Yamashita K, Miura M, Kawai T, Kohno S: Cysteinyl leukotriene-dependent interleukin-5 production leading to eosinophilia during late asthmatic response in guinea-pigs. Clin Exp Allergy. 2002 Apr;32(4):633-40.</reference_text>
        <pubmed_id>11972613</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Nogimura M, Nagata M, Sutani A, Saito K, Sakamoto Y: [Study on the effect of cysteinyl leukotriene antagonist, pranlukast hydrate, on adhesive interaction between eosinophils and pulmonary endothelial cells]. Nihon Kokyuki Gakkai Zasshi. 2002 Dec;40(12):919-24.</reference_text>
        <pubmed_id>12692940</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Fukushima C, Matsuse H, Hishikawa Y, Kondo Y, Machida I, Saeki S, Kawano T, Tomari S, Obase Y, Shimoda T, Koji T, Kohno S: Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism. Int Arch Allergy Immunol. 2005 Feb;136(2):165-72. Epub 2005 Jan 12.</reference_text>
        <pubmed_id>15650315</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Matsuse H, Kondo Y, Machida I, Kawano T, Saeki S, Tomari S, Obase Y, Fukushima C, Mizuta Y, Kohno S: Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma. Ann Allergy Asthma Immunol. 2006 Jul;97(1):55-60.</reference_text>
        <pubmed_id>16892782</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
